CN103819483A - 防治肺动脉高压的药物及其合成和应用 - Google Patents

防治肺动脉高压的药物及其合成和应用 Download PDF

Info

Publication number
CN103819483A
CN103819483A CN 201410052946 CN201410052946A CN103819483A CN 103819483 A CN103819483 A CN 103819483A CN 201410052946 CN201410052946 CN 201410052946 CN 201410052946 A CN201410052946 A CN 201410052946A CN 103819483 A CN103819483 A CN 103819483A
Authority
CN
Grant status
Application
Patent type
Prior art keywords
drug
resveratrol
out
pulmonary
iso
Prior art date
Application number
CN 201410052946
Other languages
English (en)
Chinese (zh)
Other versions
CN103819483B (zh )
Inventor
王剑波
王平安
冯力
王雷琛
张迪
Original Assignee
中国人民解放军第四军医大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
CN 201410052946 2014-02-18 2014-02-18 防治肺动脉高压的药物及其合成和应用 CN103819483B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201410052946 CN103819483B (zh) 2014-02-18 2014-02-18 防治肺动脉高压的药物及其合成和应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201410052946 CN103819483B (zh) 2014-02-18 2014-02-18 防治肺动脉高压的药物及其合成和应用

Publications (2)

Publication Number Publication Date
CN103819483A true true CN103819483A (zh) 2014-05-28
CN103819483B CN103819483B (zh) 2016-04-13

Family

ID=50754811

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201410052946 CN103819483B (zh) 2014-02-18 2014-02-18 防治肺动脉高压的药物及其合成和应用

Country Status (1)

Country Link
CN (1) CN103819483B (it)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1401654A (zh) * 2002-08-07 2003-03-12 陕西赛德高科生物股份有限公司 具有降低肺动脉高压、改善呼吸功能用途的芪三酚类化合物
CN101597231A (zh) * 2009-07-10 2009-12-09 中国人民解放军第四军医大学 No供体药物及其合成方法
CN101704752A (zh) * 2009-07-10 2010-05-12 中国人民解放军第四军医大学 抗缺血/再灌注损伤的药物
CN102336790A (zh) * 2011-07-01 2012-02-01 中国人民解放军第四军医大学 一氧化氮供体型虎杖苷衍生物、制备方法及医药用途
CN103288605A (zh) * 2013-06-06 2013-09-11 陕西师范大学 考布他丁的合成方法
WO2013147629A1 (en) * 2012-03-29 2013-10-03 Uniwersytet Medyczny Im. Karola Marcinkowskiego The new derivatives of (z)-1,2-diphenylethene
CN103421057A (zh) * 2013-08-14 2013-12-04 合肥医工医药有限公司 康普瑞汀氨基糖缀合物、其制法及其医药用途

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1401654A (zh) * 2002-08-07 2003-03-12 陕西赛德高科生物股份有限公司 具有降低肺动脉高压、改善呼吸功能用途的芪三酚类化合物
CN101597231A (zh) * 2009-07-10 2009-12-09 中国人民解放军第四军医大学 No供体药物及其合成方法
CN101704752A (zh) * 2009-07-10 2010-05-12 中国人民解放军第四军医大学 抗缺血/再灌注损伤的药物
CN102336790A (zh) * 2011-07-01 2012-02-01 中国人民解放军第四军医大学 一氧化氮供体型虎杖苷衍生物、制备方法及医药用途
WO2013147629A1 (en) * 2012-03-29 2013-10-03 Uniwersytet Medyczny Im. Karola Marcinkowskiego The new derivatives of (z)-1,2-diphenylethene
CN103288605A (zh) * 2013-06-06 2013-09-11 陕西师范大学 考布他丁的合成方法
CN103421057A (zh) * 2013-08-14 2013-12-04 合肥医工医药有限公司 康普瑞汀氨基糖缀合物、其制法及其医药用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张峰等: "一氧化氮供体预处理对乳鼠心肌细胞的延迟保护作用及其机制", 《中国药理学通报》, vol. 20, no. 4, 30 April 2004 (2004-04-30), pages 438 - 442 *

Also Published As

Publication number Publication date Type
CN103819483B (zh) 2016-04-13 grant

Similar Documents

Publication Publication Date Title
Rayner et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
Elmarakby et al. TNF-α inhibition reduces renal injury in DOCA-salt hypertensive rats
Stangier et al. Absorption, metabolism, and excretion of intravenously and orally administered [14C] telmisartan in healthy volunteers
Brodie et al. The fate of antipyrine in man
Ros et al. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat
Radomski et al. The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia‐induced lung injury in newborn rats
US6162829A (en) (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics
Enseleit et al. Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study
Tsoyi et al. HO-1 and JAK-2/STAT-1 signals are involved in preferential inhibition of iNOS over COX-2 gene expression by newly synthesized tetrahydroisoquinoline alkaloid, CKD712, in cells activated with lipopolysacchride
Alderton et al. GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo
Bruce et al. Excretion, distribution, and metabolism of doxapram hydrochloride
Su et al. Inhibition of inducible nitric oxide synthase attenuates acute endotoxin‐induced lung injury in rats
US20140249169A1 (en) 1-pyrazolyl-3- (4- ((2 -anilinopyrimidin- 4 - yl) oxy) napththalen- 1- yl) ureas as p38 map kinase inhibitors
Kates et al. Metabolite cumulation during chronic propafenone dosing in arrhythmia
Li et al. Simultaneous determination of danshensu, ferulic acid, cryptotanshinone and tanshinone IIA in rabbit plasma by HPLC and their pharmacokinetic application in danxiongfang
Joskova et al. Acute bronchodilator effect of quercetin in experimental allergic asthma
Hikino et al. Antiinflammatory principle of Ephedra herbs
Pounder et al. Zopiclone poisoning: tissue distribution and potential for postmortem diffusion
Boyland et al. Metabolism of polycyclic compounds. 11. The conversion of naphthalene into 2-hydroxy-1-naphthyl sulphate in the rabbit
Shao et al. Simvastatin suppresses lung inflammatory response in a rat cardiopulmonary bypass model
Seeberg et al. Absorption and distribution of salicylamide
Wang et al. Tissue distribution and elimination of [14C] apixaban in rats
Wang et al. Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia: a randomized controlled trial
Chen et al. Ligustrazine derivatives. Part 5: design, synthesis and biological evaluation of novel ligustrazinyloxy-cinnamic acid derivatives as potent cardiovascular agents
Wu et al. Discovery and evaluation of piperid-4-one-containing mono-carbonyl analogs of curcumin as anti-inflammatory agents

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
C14 Grant of patent or utility model